Jan H von der Thusen
Overview
Explore the profile of Jan H von der Thusen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
123
Citations
1866
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
41.
Wijchers S, von der Thusen J, Robertus J, Caliskan K
Cardiovasc Pathol
. 2021 Nov;
57:107395.
PMID: 34752915
Noncompaction cardiomyopathy is a well-known clinical entity, whereas phospholamban gene mutation is a relatively recently known mutation with phenotypes as arrhythmogenic cardiomyopathy and dilated cardiomyopathy. We report the case of...
42.
Belderbos R, Aerts J, von der Thusen J
JTO Clin Res Rep
. 2021 Nov;
2(9):100215.
PMID: 34734195
No abstract available.
43.
Hermans B, Derks J, Hillen L, van der Baan I, van den Broek E, von der Thusen J, et al.
Int J Cancer
. 2021 Oct;
150(5):802-815.
PMID: 34674268
Up to 14% of large cell neuroendocrine carcinomas (LCNECs) are diagnosed in continuity with nonsmall cell lung carcinoma. In addition to these combined lesions, 1% to 7% of lung tumors...
44.
Ooms J, Hirsch A, von der Thusen J, Michels M, Van Mieghem N
JACC Cardiovasc Interv
. 2021 Oct;
14(21):e297-e299.
PMID: 34656495
No abstract available.
45.
Belderbos R, Maat A, Baart S, Madsen E, Bogers A, Cornelissen R, et al.
JTO Clin Res Rep
. 2021 Sep;
2(4):100155.
PMID: 34590009
Introduction: The role of surgery for early stage malignant pleural mesothelioma (MPM) remains controversial. Current expert opinion is only to treat patients surgically as part of multimodality therapy. It is...
46.
Mentink J, Paats M, Dumoulin D, Cornelissen R, Elbers J, Maat A, et al.
Transl Lung Cancer Res
. 2021 Aug;
10(7):3329-3338.
PMID: 34430370
Objective: In this review, the concept of (synchronous) oligometastatic disease in patients with non-oncogene-driven non-small cell lung cancer (NSCLC) will be placed in the context of tumor biology and metastatic...
47.
van der Boon R, den Dekker W, Meuwese C, Lorusso R, von der Thusen J, Constantinescu A, et al.
Circ Heart Fail
. 2021 Aug;
14(8):e008387.
PMID: 34344163
Background: Endomyocardial biopsy (EMB) has an important role in determining the pathogenesis of new-onset acute heart failure (new-AHF) when noninvasive testing is impossible. However, data on safety and histopathologic outcomes...
48.
Derks J, Rijnsburger N, Hermans B, Moonen L, Hillen L, von der Thusen J, et al.
J Thorac Oncol
. 2021 Jun;
16(10):1632-1646.
PMID: 34139363
Diagnosing a pulmonary neuroendocrine neoplasm (NEN) may be difficult, challenging clinical decision making. In this review, the following key clinical and pathologic issues and informative molecular markers are being discussed:...
49.
Roest S, Brugts J, van Kampen J, von der Thusen J, Constantinescu A, Caliskan K, et al.
Int J Infect Dis
. 2021 Apr;
107:34-36.
PMID: 33862215
This report describes the first heart transplantation recipient with acute biventricular heart failure symptoms caused by a post-myocarditis state, late after a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection....
50.
Radonic T, Geurts-Giele W, Samsom K, Roemen G, von der Thusen J, Thunnissen E, et al.
J Thorac Oncol
. 2021 Feb;
16(5):798-806.
PMID: 33588111
Introduction: RET gene fusions are established oncogenic drivers in 1% of NSCLC. Accurate detection of advanced patients with RET fusions is essential to ensure optimal therapy choice. We investigated the...